Tom L. Ward, Chief Executive Officer and director of Mach Natural Resources LP, filed a Form 4 on November 12, 2026, disclosing two open-market purchases of common units totaling 110,000 units made on November 9 and November 10, 2026.
AkzoNobel N.V. filed a Form 425 on November 12, 2026, publishing a media release regarding the UK Competition and Markets Authority's Phase 1 decision on the proposed merger between AkzoNobel and Axalta Coating Systems Ltd.
AC Nordic ApS, a director and 10% owner of Nordicus Partners Corp, filed a Form 4 on November 12, 2026, disclosing a purchase of 20,000 shares of common stock on July 8, 2026, reported late due to an inadvertent administrative error.
Director Konstantinos Zacharatos filed a Form 4 with the SEC on November 12, 2026, reporting the purchase of 1,218 Series D Preferred Shares of Costamare Inc. on November 10, 2026.
A Schedule 13G was filed on November 12, 2026, by DCVC V, L.P., DCVC VI, L.P., their respective general partners, and managing members Matthew Ocko and Zachary Bogue, disclosing beneficial ownership positions in Agility Robotics, Inc. common stock as of November 4, 2026.
A group of six reporting persons affiliated with DCVC filed an initial statement of beneficial ownership with the SEC on November 12, 2026, disclosing aggregate holdings in Agility Robotics, Inc. (NASDAQ:AGLT) as of a triggering event dated November 4, 2026.
Gregory D. Wasson and G&K Investment Holdings LLC filed a joint initial statement of beneficial ownership with the SEC on November 11, 2026, disclosing securities acquired in ADM Tronics Unlimited, Inc.'s private placement that closed on October 27, 2026.
Eric L. Oliver, a director and 10% owner of San Juan Basin Royalty Trust (NYSE:SJT), filed a Form 4 on November 11, 2026, disclosing two open-market purchases of Units of Beneficial Interest made on November 9 and November 10, 2026, through SoftVest, LP.
Eric L. Oliver, a director and 10% owner, filed an initial statement of beneficial ownership (Form 3) with the SEC on November 11, 2026, disclosing holdings in San Juan Basin Royalty Trust as of a triggering event dated November 9, 2026.
Richard Daniell, Executive VP European Commercial at Teva Pharmaceutical Industries Ltd, filed a Form 144 notice on November 11, 2026, proposing the sale of 20,003 ordinary shares acquired through a stock option exercise and sale on the same date.